Changeflow GovPing Pharma & Drug Safety Acid Sophorolipid Composition with Suppressed B...
Routine Notice Added Final

Acid Sophorolipid Composition with Suppressed Browning

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 31st, 2026
Detected March 31st, 2026
Email

Summary

USPTO granted patent US12589154B2 to SARAYA CO., LTD. for an acidic sophorolipid-containing composition with suppressed browning. The patent covers compositions meeting specific hue value (≤5 Abs. 440) and ethanol-insoluble content (<3 mass%) thresholds, along with production methods. Seven claims protect the composition and its method of manufacture.

What changed

USPTO issued Patent No. US12589154B2 to SARAYA CO., LTD. (inventors: Michiaki Araki, Yoshihiko Hirata) on March 31, 2026. The patent claims an acidic sophorolipid-containing composition with suppressed browning, characterized by a filtrate of the hydrolysate meeting specific criteria: hue value (Abs. 440) of 5 or less, and/or ethanol-insoluble content of less than 3 mass%. The composition derives from lactonic and acidic sophorolipid hydrolysis.

This is a granted patent conferring exclusionary intellectual property rights. Competitors developing similar sophorolipid-based compositions for cosmetics (A61K8/9728), food applications (A23L33/14), or cleaning products (C11D1/36) should design around these claims. No regulatory compliance actions are required; this is an IP notification. Patent term runs 20 years from the January 15, 2020 filing date.

Source document (simplified)

← USPTO Patent Grants

Acid type sophorolipid-containing composition which is suppressed in browning

Grant US12589154B2 Kind: B2 Mar 31, 2026

Assignee

SARAYA CO., LTD.

Inventors

Michiaki Araki, Yoshihiko Hirata

Abstract

The present invention provides an acidic sophorolipid-containing composition with suppressed browning and a method for producing the composition. The acidic sophorolipid-containing composition with suppressed browning according to the present invention is characterized in that a filtrate of a hydrolysate of a composition containing lactonic sophorolipid and acidic sophorolipid, i.e., a filtrate of the acidic sophorolipid-containing composition, has at least one of the following features (1) and (2):
(1) hue value (Abs. 440): 5 or less; and(2) ethanol-insoluble content: less than 3 mass %.

CPC Classifications

A61K 47/46 A61K 8/9728 A61K 2800/805 A61K 8/498 A61K 8/604 A61K 2800/10 A61K 2800/26 A23L 33/14 A23L 29/04 A23L 29/10 A23L 29/00 A61Q 19/00 A61Q 19/10 C11D 1/36 A23V 2002/00 C07H 1/00 C07H 15/04 C12P 19/44

Filing Date

2020-01-15

Application No.

17618358

Claims

7

View original document →

Named provisions

Acid Sophorolipid-Containing Composition Browning Suppression Method Filtrate Hue Value Requirements Ethanol-Insoluble Content Limits

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12589154B2

Who this affects

Applies to
Drug manufacturers Food manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3114 Food & Beverage Manufacturing 3341 Computer & Electronics Manufacturing
Activity scope
Patent Rights Composition Manufacturing Intellectual Property Licensing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Consumer Protection Product Safety

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.